drugset / Trial / NCT05486026
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
RandomizedParallel-groupOpen-labelTreatment
Summary
Osteoarthritis (OA) is the most common degenerative joint disease, affecting more than 25% of the population . Knee OA is an insidious disease related to structural changes in the joint over many years. Progressive articular damage results in a loss of the extracellular matrix of cartilage in addition to changes in subchondral bone. Duloxetine, a selective serotonin, and norepinephrine reuptake inhibitor, it seems to be effective in treating neuropathic and chronic pain conditions.
Timeline
- Start
- 2022-08-20
- Primary completion
- 2022-12-29
- Completion
- 2023-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 30 mg | — |